ITGAM and breast cancer: Profound proteomic differences have been reported between CD11b+Gr1+ cells isolated from the spleens of 4T1 or 67NR tumor-bearing mice [49], providing further evidence that CD11b+Gr1+ cells can be phenotypically and functionally distinct in mice with different mammary tumor types.